Rotavirus Vaccine Significantly Reduces Mortality from Rotavirus-Associated Acute Gastroenteritis in Children Under 5: Insights from the MNSSTER-V Global Dataset
Highlight
This large pooled case-control study from the Multi-National Subpopulations Study to Evaluate Rotavirus Vaccines (MNSSTER-V) dataset shows that rotavirus vaccination provides 75.8% effectiveness against rotavirus-positive acute gastroenteritis mortality in children under five. Despite a smaller, non-significant reduction against all-cause acute gastroenteritis deaths, these findings highlight the critical importance of rotavirus vaccines in global child health. Continuous efforts to improve vaccine coverage could substantially reduce diarrhoeal deaths worldwide.
Study Background
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
